The Berwyn Group Appoints Adam Wilson as General Manager of Healthcare

Veteran Leader Brings Deep Industry Expertise to Advance Berwyn’s Healthcare Strategy

INDEPENDENCE, Ohio, June 13, 2025 /PRNewswire/ — The Berwyn Group (Berwyn), the leader in death audit, locate services and population management, is pleased to announce the hiring of Adam Wilson as General Manager of Healthcare. Wilson brings extensive healthcare industry experience that will further strengthen Berwyn’s commitment to excellence and growth.  

Berwyn offers an end-to-end suite of industry-leading death audit and locate solutions that enable pension and health plan administrators to eliminate costly overpayments, maximize efficiency, meet regulatory requirements, and connect policyholders, participants and beneficiaries to the funds they deserve. More than 2,000 corporate, union and government clients use Berwyn’s flagship services, CertiDeath® and CertiCensus®

Wilson joins Berwyn with a distinguished career that spans almost 17 years at UnitedHealthcare, where he held several leadership roles including Vice President of Workforce Planning, Chief of Staff to the COO, and Vice President of Medicare Part D products.

“We are thrilled to welcome Adam to the team,” said John Bikus, President of Berwyn. “His strategy, proven leadership, and deep industry knowledge will be invaluable as we continue to grow in the healthcare industry.”

In his new role, Wilson will be responsible for leading Berwyn’s strategic expansion into the healthcare market. He will be focusing on aligning Berwyn’s solutions to the healthcare payer and provider business cycle needs while also extending the Berwyn reach to healthcare-related supporting partners, vendors, and industry trade groups.

“I’m eager to join an organization positioned for rapid growth through industry-leading capabilities,” said Wilson. “I look forward to collaborating with the talented team at Berwyn to deliver quick wins, strategic expansion into healthcare, and contribute to the company’s continued success.”

About The Berwyn Group

The Berwyn Group is the leader in population data management, offering the industry’s most trusted and effective death audit and locate solutions, with an unmatched dedication to innovation, security, and generating outcomes. Acquired by Longevity Holdings in 2023, The Berwyn Group offers an end-to-end suite of industry-leading solutions including CertiDeath® Paragon™, CertiDeath®, CertiCensus®, CertiSearch® and BeneSearch®. Connecting leading-edge technology and data with best-in-class human ingenuity, Berwyn helps bridge the gap between pensions and their participants, insurance companies and their policyholders, third-party administrators and public entities with Medicaid recipients. For more information, visit www.berwyngroup.com.

Media Contact

Karlene Gilmore

Director of Marketing

kgilmore@berwyngroup.com 

View original content:https://www.prnewswire.com/news-releases/the-berwyn-group-appoints-adam-wilson-as-general-manager-of-healthcare-302481503.html

SOURCE The Berwyn Group, Inc.

Staff

Recent Posts

Best Ipamorelin vs Sermorelin: Growth Hormone Peptide Comparison 2026 — ReadyRx Prescription Telehealth Analysis

Independent research summary reviews mechanisms, regulatory considerations, and telehealth access pathways as consumers compare growth…

24 minutes ago

GLP-1 Booster From Health Journey: 2026 Ingredient Analysis And Probiotic Metabolic Support Explained

Examining Akkermansia Muciniphila, Clostridium Butyricum, And The Gut Microbiome Research Behind This Probiotic GLP-1 Supplement…

24 minutes ago

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Independent Analysis Examines MEDVi's Semaglutide Medication Model, FDA Compounding Framework, and Prescription Accessibility Trends Heading…

25 minutes ago

Best Peptides for Anti-Aging: NAD+ Delivery Methods Compared as Telehealth Platforms Expand Access (2026 Analysis)

Published NAD+ research examines cellular aging pathways and mitochondrial function as prescription peptide injection access…

25 minutes ago

Foghorn Therapeutics Highlights January Equity Financing, Program Progress and Strategic Objectives for 2026

Recently raised $50 million with BVF Partners, Deerfield Management, founding investor Flagship Pioneering and a…

25 minutes ago

Anti-Snoring Mouthpiece vs Nose Strips: Consumer Analysis Explains Why Product Format May Matter More Than Brand

How Jaw-Positioning Devices and Nasal Products Differ — SleepZee Examined Within Mouthpiece Category ContextChicago, IL,…

25 minutes ago